Although our understanding of the association between breast implants and anaplastic large-cell lymphoma (ALCL) has increased since the first published case report in 1997,¹ questions about this unique clinicopathological entity still outnumber the answers. What causes breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)? Who is at risk? How great is the risk? What is the optimal treatment?

中文翻译：

---

乳房植入物与间变性大细胞淋巴瘤的关联

尽管自 1997 年首次发表病例报告以来，我们对乳房植入物与间变性大细胞淋巴瘤 (ALCL) 之间关联的了解有所增加，但关于这一独特临床病理学实体的^{1 个}问题仍然多于答案。是什么导致了乳房植入物相关的间变性大细胞淋巴瘤 (BIA-ALCL)？谁有风险？风险有多大？什么是最佳治疗？